Harpoon Therapeutics, Inc. Profile Avatar - Palmy Investing

Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United…

Biotechnology
US, South San Francisco [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of HARP's Analysis
CIK: 1708493 CUSIP: 41358P106 ISIN: US41358P2056 LEI: - UEI: -
Secondary Listings
HARP has no secondary listings inside our databases.